Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireNov 29 16:05 ET

Express News | Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersNov 29 16:05 ET

Express News | Bvf Partners LP Reports 8.2% Passive Stake in Verve Therapeutics Inc as of Nov 11 - SEC Filing

ReutersNov 18 17:31 ET

ARKK's Holdings Ranked by SA Quant Grades

Seeking AlphaNov 12 14:21 ET

CRISPR, Beam, Other Gene Editing Names up Significantly

Seeking AlphaNov 11 13:15 ET

RBC Capital Maintains Verve Therapeutics(VERV.US) With Buy Rating, Cuts Target Price to $17

Moomoo NewsNov 6 13:32 ET · Ratings